Cargando…
Engineering hematopoietic stem cells to create melanoma specific CTL
Using a humanized mouse model, we developed melanoma specific CD8 T cells from genetically modified human hematopoietic stem cells (hHSC). The transgenic T cells were functional both in vivo and ex vivo, effectively limiting and clearing tumor growth. Finally, the transduced hHSC stably populated th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382894/ https://www.ncbi.nlm.nih.gov/pubmed/22754779 |
_version_ | 1782236569356206080 |
---|---|
author | Vatakis, Dimitrios |
author_facet | Vatakis, Dimitrios |
author_sort | Vatakis, Dimitrios |
collection | PubMed |
description | Using a humanized mouse model, we developed melanoma specific CD8 T cells from genetically modified human hematopoietic stem cells (hHSC). The transgenic T cells were functional both in vivo and ex vivo, effectively limiting and clearing tumor growth. Finally, the transduced hHSC stably populated the bone marrow. |
format | Online Article Text |
id | pubmed-3382894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-33828942012-07-01 Engineering hematopoietic stem cells to create melanoma specific CTL Vatakis, Dimitrios Oncoimmunology Author's View Using a humanized mouse model, we developed melanoma specific CD8 T cells from genetically modified human hematopoietic stem cells (hHSC). The transgenic T cells were functional both in vivo and ex vivo, effectively limiting and clearing tumor growth. Finally, the transduced hHSC stably populated the bone marrow. Landes Bioscience 2012-07-01 /pmc/articles/PMC3382894/ /pubmed/22754779 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Vatakis, Dimitrios Engineering hematopoietic stem cells to create melanoma specific CTL |
title | Engineering hematopoietic stem cells to create melanoma specific CTL |
title_full | Engineering hematopoietic stem cells to create melanoma specific CTL |
title_fullStr | Engineering hematopoietic stem cells to create melanoma specific CTL |
title_full_unstemmed | Engineering hematopoietic stem cells to create melanoma specific CTL |
title_short | Engineering hematopoietic stem cells to create melanoma specific CTL |
title_sort | engineering hematopoietic stem cells to create melanoma specific ctl |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382894/ https://www.ncbi.nlm.nih.gov/pubmed/22754779 |
work_keys_str_mv | AT vatakisdimitrios engineeringhematopoieticstemcellstocreatemelanomaspecificctl |